Home › Funds › MONTANOVA CAPITAL, LLC › PVLA

MONTANOVA CAPITAL, LLC position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

MONTANOVA CAPITAL, LLC reported holding 1,135,406 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$173.5M, representing 3.17% of its reported portfolio and ranking #5 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed PVLA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.14M sh
Reported value held$173.51M
Portfolio Weight3.17%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MONTANOVA CAPITAL, LLC's PVLA position evolved

MONTANOVA CAPITAL, LLC first disclosed a stake in PVLA in Q4 2024 at 714,463 shares (US$8.6M). The position peaked in Q2 2026 at 1,135,406 shares, worth US$173.5M. Across 7 filings, MONTANOVA CAPITAL, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,135,406 shares valued at US$173.5M — a reduction of -18,090 shares quarter over quarter.. Notable position changes include a 29% increase in Q1 2026 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 714.46K $8.57M New
Q1 2025 714.46K $20.00M Hold
Q2 2025 714.46K $16.10M Hold
Q3 2025 822.40K $51.56M Add
Q4 2025 892.40K $93.41M Add
Q1 2026 1.15M $143.78M Add
Q2 2026 1.14M $173.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M), BVF INC/IL (US$102.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has MONTANOVA CAPITAL, LLC held PVLA?

MONTANOVA CAPITAL, LLC has disclosed PVLA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is MONTANOVA CAPITAL, LLC's current position in PVLA?

As of Q2 2026, MONTANOVA CAPITAL, LLC holds 1.14M shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $173.51M, representing 3.17% of its reported portfolio and ranking #5.

Has MONTANOVA CAPITAL, LLC been buying or selling PVLA?

In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC reduced its position in PVLA. The position peaked in Q2 2026 at 1.14M shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, BVF INC/IL, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.